He recently received the ARCF’s 2017 Forest Bird Lifetime Scientific Achievement Award. He serves on the editorial board for the Journal of Aerosol Medicine and Pulmonary Drug Delivery and Inhalation. Fink has authored 3 textbooks and >120 chapters and peer reviewed papers. Jim is a Registered Respiratory Therapist and Neonatal Pediatric Specialist, with a PhD in Pharmaceutical Innovation from Bradford University, UK and a Fellow of both the American Association of Respiratory Care (FAARC) and the College of Chest Physicians (FCCP). Fink led the development and implementation of aerosol devices for administration of inhaled measles vaccines in mass campaigns in developing countries and has been active in design development of liquid breath actuated insulin inhaler as well as systems for surfactant delivery to low birth weight infants, with multiple US and international patents. Jim has developed high efficiency liquid aerosol delivery systems for infants and adults, including administration of Surfactant to preterm infants and Amikacin to adults both on and off mechanical ventilation.ĭr. A respiratory care clinician, supervisor, manager, educator and researcher for 45+ years with the past 25 years dedicated to understanding aerosol device/patient interface and design in both critical care and ambulatory settings. Jimmy Fink studied drama at the University of Arizona from 196769 and received a BA degree in Speech Arts/Communications from The American University in. Reporter-Economic Development, Sports & Tourism, Canada for Buffalo Business First.

He is part of the family which owned the Fink Bakery, a New York City fixture from 1888 to 2000 located in Manhattan and Long Island City. Fink is an Adjunct Professor of Respiratory Therapy at Rush Medical School, Chicago, Texas State University and Visiting Professor, Department of Physical therapy, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil (CNPq 400801/2013-2). Fink was born and raised in Eastchester, New York. Besides his passion for analyzing and writing about stocks, Jim likes to hike in the desert Southwest, vacation in Las Vegas, play tennis, and feed his toddler son Cheerios.Chief Science Officer Aerogen Pharma CorporationĬurrently serves as Chief Scientific Officer for Aerogen Pharma Corporation in San Mateo, CA and Senior Fellow of Aerosol Device Development for Dance Biopharm in Brisbane, CA. The dangers of showing off while riding bicycles is related by a boy whose young brother foolishly disregarded safety instructions. After attending business school, Jim switched gears to the investment realm full-time, working for a university endowment, a private wealth management firm, an insurance and financial planning company, and as a Senior Analyst for an online investment newsletter service that encourages the wearing of funny hats.Ī possible but unlikely descendant of legendary brawler and boatman Mike Fink, Jim defies his heritage, believing that investing success requires patience and analysis, not swashbuckling bravado. Prior to joining Investing Daily, and when not incurring student loans hiding out in academe, Jim practiced telecommunications regulatory law for nine years until he realized that he made more money trading stock options than writing briefs. For good measure, he has been a member of the Illinois and D.C. Hopelessly overeducated, Jim holds a bachelor's degree from Yale University, a master's degree from Harvard's Kennedy School of Government, a law degree from Columbia University, and an MBA from the University of Virginia's Darden School of Business. James Fink District Operations Manager, DENNYS RESTAURANTS Brand Communications Manager Field Marketing Manager People Ive Reported To People Ive Worked.

Jim also serves as an investment analyst at Investing Daily’s flagship investing publication, Personal Finance.

He has traded options for more than 30 years and generated personal profits of more than $5 million. Jim Fink is chief investment strategist for Options for Income, Velocity Trader, and Jim Fink's Inner Circle.

Jim fink review